论文部分内容阅读
1 资料与方法 1.1 病例选择 选择我院同期住院患者84例,随机分成治疗组和对照组。治疗组44例,男性30例,女性14例,年龄16～65岁,平均38.5岁。其中急性肝炎13例,慢性肝炎18例,肝炎后肝硬变10例,重型肝炎3例;对照组40例,男性28例,女性12例,年龄15～60岁,平均35.2岁,其中急性肝炎13例,慢性肝炎16例,肝炎后肝硬变8例,重型肝炎3例。两纽病例在性别、年龄、病情等方面具有可比性。诊断符合1995年北京第五次全国传染病、寄生虫病学术会议讨论修订标准。全部病例均经大便常规检查及培养,排除感染性腹泻。 1.2 治疗方法 对照组:根据不同类型采用能量合剂、门冬氨酸钾镁、丹参注射液等综合治疗。治疗组:在综合治疗的基础
1 Materials and Methods 1.1 Case Selection 84 cases of hospitalized patients in our hospital at the same period, were randomly divided into treatment group and control group. Treatment group of 44 patients, 30 males and 14 females, aged 16 to 65 years, mean 38.5 years. Including acute hepatitis in 13 cases, chronic hepatitis in 18 cases, posthepatitic cirrhosis in 10 cases, severe hepatitis in 3 cases; control group of 40 cases, 28 males and 12 females, aged 15 to 60 years, mean 35.2 years, of which acute hepatitis 13 cases, 16 cases of chronic hepatitis, cirrhosis of the liver in 8 cases, 3 cases of severe hepatitis. Two New York cases in gender, age, illness and other aspects of comparability. Diagnosis in line with the Fifth National Conference on Infectious Diseases and Parasitology in Beijing in 1995 to discuss the revised standards. All cases were stool routine examination and training to rule out infectious diarrhea. 1.2 Treatment control group: According to different types of energy mixture, potassium magnesium aspartate, Salvia injection and other comprehensive treatment. Treatment group: The basis of comprehensive treatment